The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines
暂无分享,去创建一个
M. McCarthy | M. Sammeth | G. Lunter | P. Marchetti | D. Eizirik | T. Bouckenooghe | G. Bottu | G. Sisino | M. Igoillo-Esteve | F. Ortis | I. Santin | M. Colli | J. Barthson | L. Bouwens | L. Hughes | Lorna Gregory | L. Marselli | M. Cnop | M. McCarthy | L. Gregory | Jenny Barthson | M. McCarthy | Izortze Santin
[1] C B Wollheim,et al. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.
[2] N. Welsh,et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] N. Welsh,et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.
[4] N. Welsh,et al. Differences in the Expression of Heat-Shock Proteins and Antioxidant Enzymes between Human and Rodent Pancreatic Islets: Implications for the Pathogenesis of Insulin-Dependent Diabetes Mellitus , 1995, Molecular medicine.
[5] A. Karsan,et al. Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.
[6] R. Scharfmann,et al. Expression of Neuronal Traits in Pancreatic Beta Cells , 1997, The Journal of Biological Chemistry.
[7] S. Lenzen,et al. Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.
[8] Robert B Darnell,et al. Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.
[9] T. Mandrup-Poulsen,et al. A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.
[10] C. Mathieu,et al. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells , 2001, Diabetologia.
[11] M. Kruhøffer,et al. Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. , 2001, Diabetes.
[12] M. Redondo,et al. Genetics of type 1A diabetes. , 2001, Recent progress in hormone research.
[13] Dongbo Liu,et al. Double-Stranded RNA Cooperates with Interferon-γ and IL-1β to Induce Both Chemokine Expression and Nuclear Factor-κB-Dependent Apoptosis in Pancreatic β-Cells: Potential Mechanisms for Viral-Induced Insulitis and β-Cell Death in Type 1 Diabetes Mellitus. , 2002, Endocrinology.
[14] Christopher J. Lee,et al. A genomic view of alternative splicing , 2002, Nature Genetics.
[15] C. Furusawa,et al. Zipf's law in gene expression. , 2002, Physical review letters.
[16] Jernej Ule,et al. CLIP Identifies Nova-Regulated RNA Networks in the Brain , 2003, Science.
[17] D. Eizirik,et al. Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.
[18] Gene microarray study corroborates proteomic findings in rodent islet cells. , 2003, Journal of proteome research.
[19] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[20] R. Darnell,et al. Nova Regulates GABAA Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer , 2003, Molecular and Cellular Biology.
[21] A. K. Cardozo,et al. Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic beta-cells. , 2003, Diabetes.
[22] C. Mathieu,et al. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.
[23] Mogens Kruhøffer,et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. , 2003, Diabetes.
[24] U. Boggi,et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. , 2004, The Journal of clinical endocrinology and metabolism.
[25] Christopher J. Lee,et al. Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. , 2004, Nucleic acids research.
[26] F. Ortis,et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. , 2005, Diabetes.
[27] S. Akira,et al. Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-γ-induced Apoptosis in Primary Pancreatic β-Cells* , 2005, Journal of Biological Chemistry.
[28] U. Boggi,et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.
[29] P. Rorsman,et al. Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels. , 2005, Genome research.
[30] R. Lahesmaa,et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets , 2005, Diabetologia.
[31] Brian J. Smith,et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.
[32] Alvin C. Powers,et al. Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[33] F. Ortis,et al. Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-kappaB activation. , 2006, Molecular endocrinology.
[34] David Haussler,et al. Unusual Intron Conservation near Tissue-Regulated Exons Found by Splicing Microarrays , 2005, PLoS Comput. Biol..
[35] Camillo Ricordi,et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[36] U. Boggi,et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.
[37] R. A. Bailey,et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.
[38] Junying Yuan,et al. Selective Inhibition of Eukaryotic Translation Initiation Factor 2α Dephosphorylation Potentiates Fatty Acid-induced Endoplasmic Reticulum Stress and Causes Pancreatic β-Cell Dysfunction and Apoptosis* , 2006, Journal of Biological Chemistry.
[39] Tatiana Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[40] J. Ule,et al. Evolution of Nova-Dependent Splicing Regulation in the Brain , 2007, PLoS genetics.
[41] P. Taylor,et al. Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic beta-cells and the involvement of neuroligin in insulin secretion. , 2008, Endocrinology.
[42] Tsonwin Hai,et al. Initiation and execution of lipotoxic ER stress in pancreatic β-cells , 2008, Journal of Cell Science.
[43] S. Lira,et al. Islet Expression of M3 Uncovers a Key Role for Chemokines in the Development and Recruitment of Diabetogenic Cells in NOD Mice , 2008, Diabetes.
[44] M. Gerstein,et al. The Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing , 2008, Science.
[45] L. Hood,et al. Detailed transcriptome atlas of the pancreatic β cell , 2008 .
[46] N. Barbosa-Morais,et al. Tissue-specific splicing factor gene expression signatures , 2008, Nucleic acids research.
[47] W. Zong,et al. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist , 2008, Oncogene.
[48] B. Frey,et al. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.
[49] Pär Nordlund,et al. Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with Bim , 2008, FEBS letters.
[50] Marcel H. Schulz,et al. A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.
[51] S. Lenzen. Oxidative stress: the vulnerable beta-cell. , 2008, Biochemical Society transactions.
[52] J. Florez. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes? , 2008, Diabetologia.
[53] L. Hood,et al. Detailed transcriptome atlas of the pancreatic beta cell , 2009, BMC Medical Genomics.
[54] D. Eizirik,et al. Use of a systems biology approach to understand pancreatic beta-cell death in Type 1 diabetes. , 2008, Biochemical Society transactions.
[55] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[56] Tatiana A. Tatusova,et al. NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..
[57] B. Hartmann,et al. Decrypting the genome's alternative messages. , 2009, Current opinion in cell biology.
[58] S. Pugazhenthi,et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-κB) signalling in human islets and in a mouse beta cell line , 2009, Diabetologia.
[59] Torben F. Ørntoft,et al. Cytokines Interleukin-1β and Tumor Necrosis Factor-α Regulate Different Transcriptional and Alternative Splicing Networks in Primary β-Cells , 2009, Diabetes.
[60] P. Marchetti,et al. Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB , 2009, Diabetes.
[61] M. Gerstein,et al. RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.
[62] H. Mewes,et al. PPI spider: A tool for the interpretation of proteomics data in the context of protein–protein interaction networks , 2009, Proteomics.
[63] F. Ortis,et al. The role of inflammation in insulitis and β-cell loss in type 1 diabetes , 2009, Nature Reviews Endocrinology.
[64] Lili Wan,et al. RNA and Disease , 2009, Cell.
[65] J. Manley,et al. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches , 2009, Nature Reviews Molecular Cell Biology.
[66] D. Eizirik,et al. Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis , 2009, Cell Death and Differentiation.
[67] M. Bugliani,et al. PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Interferon-γ–Induced Pancreatic β-Cell Apoptosis , 2009, Diabetes.
[68] T. Ørntoft,et al. STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet Inflammation* , 2010, The Journal of Biological Chemistry.
[69] P. Marchetti,et al. p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic β-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress* , 2010, The Journal of Biological Chemistry.
[70] Marcel H. Schulz,et al. Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments , 2010, Nucleic acids research.
[71] R. Guigó,et al. Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.
[72] J. Fak,et al. Chaolin Zhang and Its Combinatorial Controls Integrative Modeling Defines the Nova Splicing-Regulatory Network , 2013 .
[73] I. Shimomura,et al. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes. , 2010, Endocrine journal.
[74] T. Hughes,et al. Most “Dark Matter” Transcripts Are Associated With Known Genes , 2010, PLoS biology.
[75] J. Norris. Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects , 2010, Current diabetes reports.
[76] D. Eizirik,et al. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA , 2009, Human molecular genetics.
[77] F. Ortis,et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes , 2010, Diabetologia.
[78] Catalin C. Barbacioru,et al. RNA-Seq analysis to capture the transcriptome landscape of a single cell , 2010, Nature Protocols.
[79] U. Boggi,et al. Islet inflammation and CXCL10 in recent‐onset type 1 diabetes , 2010, Clinical and experimental immunology.
[80] D. Clayton,et al. Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.
[81] Mark I McCarthy,et al. Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.
[82] M. V. von Herrath,et al. Protection against or triggering of Type 1 diabetes? Different roles for viral infections , 2011, Expert review of clinical immunology.
[83] Constantin Polychronakos,et al. A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci , 2011, PLoS genetics.
[84] J. van Helden,et al. Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype , 2012, PLoS ONE.
[85] P. Marchetti,et al. Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death , 2011, Diabetes.
[86] D. Eizirik,et al. Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance , 2011, PLoS pathogens.
[87] P. Marchetti,et al. PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim , 2011, Diabetes.
[88] 上田 裕紀. Etiology of type 1 diabetes , 2011 .
[89] T. Ørntoft,et al. Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation , 2012, Oncogene.